Teva Pharmaceutical Industries Ltd. Deal History & Licensing Activity
Teva Pharmaceutical Industries Ltd. is a mid-size pharma headquartered in US. Over the past three years, Teva Pharmaceutical Industries Ltd. has been involved in 3 licensing and acquisition transactions, with a primary focus on Small Molecules (3 deals).
Deals (12mo)
5
Active Trials
0
Top Modality
Small Molecules
Focus Area
Neurology
Teva Pharmaceutical Industries Ltd. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Teva Pharmaceutical Industries Ltd. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Experimental Tourette drug | Teva | Small Molecules | Phase 3 | acquisition | Apr 15, 2026 |
Teva Pharmaceutical Industries Ltd. Pipeline Focus
Therapeutic areas and modalities where Teva Pharmaceutical Industries Ltd. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Teva Pharmaceutical Industries Ltd.'s Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Neurology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Neurology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for neurology
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
Gastroenterology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for gastroenterology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
About Teva Pharmaceutical Industries Ltd. Licensing & Deal Activity
Teva Pharmaceutical Industries Ltd. is a mid-size pharma company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 3 deals over the past three years, Teva Pharmaceutical Industries Ltd. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Teva Pharmaceutical Industries Ltd. include Neurology (2 deals and trials), Infectious Disease (1 deal and trial), and Gastroenterology (1 deal and trial). In terms of modality, Teva Pharmaceutical Industries Ltd. has shown particular interest in small molecules, antibodies.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Teva Pharmaceutical Industries Ltd. and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Teva Pharmaceutical Industries Ltd.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.